Prof. Irun Cohen, the inventor of VacciGuard's technology , has held the following positions:
- Mauerberger Professor of Immunology at the Department of Immunology of the Weizmann Institute of Science
- Director, European Collaboration on T Cell Vaccination sponsored by the European Medical Research Councils of the European Science Foundation
- Director, Robert Koch-Minerva Center for Research in Autoimmune Diseases, at the Weizmann Institute of Science
- Director, Center for the Study of Emerging Diseases, Jerusalem
- Chairman, Committee for the Re-accreditation of Israeli Medical Schools, The Council for Higher Education, Israel
- Executive Director, The National Center for T-cell Vaccination, Israel
- Member of the Executive Committee of The National Center for Complexity Science, Israel
Prof. Cohen was awarded the Robert Koch Prize, Federal Republic of Germany, for his work on autoimmunity. He is a Highly Cited Researcher (ISI), with over 480 professional publications.
His major contributions include:
- Development of cloned T cells as functional probes for the analysis of autoimmune diseases
- Discovery of immune regulation by T cell vaccination - currently in phase 2 clinical trials for treatments of multiple sclerosis, lupus and arthritis
- Development of the concept of the immunological homunculus in the regulation of autoimmunity, natural and pathogenic
- Peptide vaccination therapy of type 1 Autoimmune Diabetes - at phase 3 of clinical trials
- Co-inventor of Reactive Animation - a computer-assisted, precise visual language for interactive and dynamic simulation of complex systems
- Development of a new platform for conjugate vaccines
- Development of the antigen microarray chip for bioinformatic analysis of immune system patterns.
Prof. Cohen holds an MD from Northwestern University Medical School.